<div id="readability-page-1"><div> <p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/health-catalyst-inc-logo-1200x675.jpg/query-dj0yMDIyMTIwODE1MjgzOQ?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="1200" height="675" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/logos/health-catalyst-inc-logo-1200x675.jpg/query-dj0yMDIyMTIwODE1MjgzOQ"/>Health Catalyst, Inc. (NASDAQ:HCAT - Get Free Report) insider Linda Llewelyn sold 1,324 shares of the stock in a transaction that occurred on Tuesday, October 15th. The shares were sold at an average price of $8.16, for a total transaction of $10,803.84. Following the sale, the insider now directly owns 114,275 shares of the company's stock, valued at $932,484. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website.</p><ul><li>The 10 Top-Rated Stocks by Wall Street Analysts in June 2021</li></ul><p>Linda Llewelyn also recently made the following trade(s): </p><ul><li>On Monday, September 16th, Linda Llewelyn sold 1,324 shares of Health Catalyst stock. The shares were sold at an average price of $8.43, for a total transaction of $11,161.32. </li><li>On Thursday, August 15th, Linda Llewelyn sold 1,328 shares of Health Catalyst stock. The stock was sold at an average price of $6.57, for a total transaction of $8,724.96. </li></ul><h2>Health Catalyst Trading Down 0.8 %</h2><p>HCAT opened at $8.65 on Friday. Health Catalyst, Inc. has a 1-year low of $5.42 and a 1-year high of $11.41. The company has a market cap of $510.65 million, a price-to-earnings ratio of -4.68 and a beta of 1.32. The company's fifty day moving average price is $7.67 and its two-hundred day moving average price is $6.93. </p><hr/><div><div><div><p>Don’t Buy Another Stock Until Reading This…</p><p><span>From Unstoppable Prosperity   |   Ad</span></p><p>Buying stocks in today's market is a gamble… Unless you're using the right proven strategy! During my upcoming FREE intro to investing online event, my team will be revealing the strategies I've developed over the past 37 years on Wall Street… </p><p>Click here to claim your seat at my Intro to Investing class now!</p></div></div></div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05OTA2?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05OTA2"/></p><hr/><p>Health Catalyst (NASDAQ:HCAT - Get Free Report) last posted its earnings results on Wednesday, August 7th. The company reported $0.12 EPS for the quarter, topping the consensus estimate of $0.08 by $0.04. Health Catalyst had a negative net margin of 28.87% and a negative return on equity of 9.38%. The company had revenue of $75.90 million during the quarter, compared to the consensus estimate of $74.96 million. During the same period in the previous year, the firm posted ($0.21) earnings per share. The firm's revenue for the quarter was up 3.7% on a year-over-year basis. As a group, equities analysts forecast that Health Catalyst, Inc. will post -0.35 earnings per share for the current fiscal year. </p><h2>Institutional Inflows and Outflows</h2><p>Large investors have recently modified their holdings of the stock. Nisa Investment Advisors LLC grew its holdings in Health Catalyst by 461.0% during the second quarter. Nisa Investment Advisors LLC now owns 6,367 shares of the company's stock worth $41,000 after buying an additional 5,232 shares in the last quarter. Quarry LP grew its stake in shares of Health Catalyst by 59.4% in the 2nd quarter. Quarry LP now owns 7,002 shares of the company's stock worth $45,000 after acquiring an additional 2,610 shares in the last quarter. nVerses Capital LLC purchased a new stake in shares of Health Catalyst in the third quarter valued at about $59,000. Perfromance Wealth Partners LLC purchased a new stake in shares of Health Catalyst in the second quarter valued at about $64,000. Finally, Mackenzie Financial Corp bought a new position in shares of Health Catalyst during the second quarter valued at about $70,000. Institutional investors own 85.00% of the company's stock. </p><h2>Wall Street Analyst Weigh In</h2><p>A number of analysts have weighed in on the company. JPMorgan Chase &amp; Co. increased their price target on Health Catalyst from $10.00 to $13.00 and gave the stock an &#34;overweight&#34; rating in a report on Wednesday, September 4th. Stephens decreased their target price on Health Catalyst from $8.00 to $7.00 and set an &#34;equal weight&#34; rating for the company in a research note on Thursday, August 8th. Piper Sandler lowered their target price on Health Catalyst from $14.00 to $11.00 and set an &#34;overweight&#34; rating for the company in a report on Monday, August 26th. Cantor Fitzgerald restated an &#34;overweight&#34; rating and set a $16.00 price target on shares of Health Catalyst in a report on Friday, October 4th. Finally, Evercore ISI lifted their price objective on shares of Health Catalyst from $8.00 to $10.00 and gave the company an &#34;outperform&#34; rating in a research note on Tuesday, October 8th. Four research analysts have rated the stock with a hold rating and eight have issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of &#34;Moderate Buy&#34; and a consensus price target of $11.58.</p><p><b>Get Our Latest Stock Report on Health Catalyst</b></p><h2>About Health Catalyst</h2><p> (Get Free Report)</p><p>Health Catalyst, Inc provides data and analytics technology and services to healthcare organizations in the United States. It operates in two segments, Technology and Professional Services. The company provides data operating system data platform which provides clients single comprehensive environment to integrate and organize data from their disparate software systems; and analytics applications, a software analytics applications build for data platform to analyze clients face across clinical and quality, population health, and financial and operational use cases.</p><h2>Read More</h2><ul><li>Five stocks we like better than Health Catalyst</li><li>Retail Stocks Investing, Explained</li><li>AI Boom Fuels Demand for Dominion Energy Stock</li><li>What is Forex and How Does it Work? </li><li>Cathie Wood Cuts Robinhood Holdings—Follow Her Lead or Stay Put?</li><li>What is a buyback in stocks? A comprehensive guide for investors</li><li>Wave Life Sciences Rockets 70% on Historic RNA Editing Success</li></ul><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SENBVA?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="650" height="350" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/InsiderTradesChart.ashx/query-UHJlZml4PU5BU0RBUSZTeW1ib2w9SENBVA"/></p><p><em>This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to [email protected].</em></p> <div> <p>Insider Buying or Selling at Health Catalyst?</p> <p>Sign-up to receive InsiderTrades.com's daily insider buying and selling report for Health Catalyst and related companies.</p>   </div> <div> <div><p>More From MarketBeat</p><div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2054push_blockchain-3277336_640.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="200" height="200" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2054push_blockchain-3277336_640.jpg"/></p><div><p>DeFi Coin on Verge of Breakout!</p><p>Grayscale Investments just announced a new fund offering access to a HOT new DeFi coin… And thanks to this ...</p><p><span>Crypto 101 Media</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05OTU1?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05OTU1"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2050push_101168394-BU003307r.1910x1000.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="250" height="131" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2050push_101168394-BU003307r.1910x1000.jpg"/></p><div><p>15 REITs That Wall Street Analysts Love in Today's Market</p><p>There are more than 200 publicly-traded real-estate investment trusts (REITs) that you can buy through your br...</p><p><span>MarketBeat</span></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2061push_capital-5043172_640.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="200" height="200" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2061push_capital-5043172_640.jpg"/></p><div><p>Tim Sykes’ Urgent Trade Alert: “Make this move now”</p><p>WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...</p><p><span>Timothy Sykes</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05Njk1?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05Njk1"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2066push_Depositphotos_551850206_S.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="250" height="187" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2066push_Depositphotos_551850206_S.jpg"/></p><div><p>7 Mid-Cap Stocks That Are Ready to Rally</p><p>One of the primary issues moving markets in 2024 is the direction of interest rates. Specifically, when will t...</p><p><span>MarketBeat</span></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2056push_trump_new-12.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="200" height="200" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2056push_trump_new-12.jpg"/></p><div><p>Crypto’s next big bull run?</p><p>Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...</p><p><span>Weiss Ratings</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05OTg3?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05OTg3"/></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2069push_Depositphotos_178767248_S.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="250" height="166" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2069push_Depositphotos_178767248_S.jpg"/></p><div><p>7 Warren Buffett Stocks to Ride Out Market Volatility</p><p>Warren Buffett has been one of the most closely watched investors in the last half-century. The “Oracle ...</p><p><span>MarketBeat</span></p></div></div><div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2065push_RedGraph-1.jpg?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="200" height="200" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/images/webpush/files/thumb_2065push_RedGraph-1.jpg"/></p><div><p>320 hedge funds just sold this stock</p><p>320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...</p><p><span>Chaikin Analytics</span><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05NjUy?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" height="1" width="1" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/TriggeredCampaignPixel.ashx/query-UGxhY2VtZW50PU5hdGl2ZURpc3BsYXkmU291cmNlPU5hdGl2ZURpc3BsYXkmVHJpZ2dlcmVkQ2FtcGFpZ25JRD05NjUy"/></p></div></div><div><p></p><div><p>7 Stocks Under $50 to Buy at 52-Week Lows</p><p>In this special presentation, we're offering you seven stocks that meet two criteria important to investors in...</p><p><span>MarketBeat</span></p></div></div></div></div> </div> </div></div>

HCAT

<p>Health Catalyst, Inc. (NASDAQ:HCAT) insider Linda Llewelyn sold 1,324 shares on October 15 at an average price of $0.16, totaling $803.84. Post-sale, Llewelyn holds 114,275 shares, reflecting a 0.00% decrease in her position. The transaction was disclosed to the SEC. Health Catalyst's stock opened at $0.65, with a market cap of $65 million and a negative net margin of 28.87%. Analysts have varied price targets, with JPMorgan raising theirs to $XX.XX and others adjusting theirs downward.</p>

Insider Selling: Health Catalyst, Inc. (NASDAQ:HCAT) Insider Sells 1,324 Shares of Stock